Zobrazeno 1 - 10
of 3 085
pro vyhledávání: '"Tillmann Hl"'
Autor:
Fettiplace A; Patient Safety, AstraZeneca, Cambridge, UK., Marcinak J; Pharmacovigilance and Patient Safety, AbbVie, North Chicago, Illinois, USA., Merz M; Independent Consultant, Germany., Zhang HT; Benefit-Risk Management and Pharmacovigilance, Bayer Pharmaceuticals, USA., Kikuchi L; Global Safety, Bayer S.A., Brazil., Regev A; Global Patient Safety, Eli Lilly and Company, Indianapolis, Indiana, USA., Palmer M; Liver Consulting LLC, New York, USA., Rockey D; Digestive Disease Research Center, Charleston, South Carolina, USA., Fontana R; University of Michigan, Ann Arbor, Michigan, USA., Hayashi PH; Food and Drug Administration, Silver Spring, Maryland, USA., Tillmann HL; East Carolina University, Greenville, North Carolina, USA., Di Bisceglie AM; Saint Louis University, St. Louis, Missouri, USA., Lewis JH; Georgetown University, Washington, DC, USA.
Publikováno v:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
Autor:
Poola S; Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, East Carolina University/ECU Health Medical Center, 601 Moye Blvd, Greenville, NC, 27834, USA., Kratzer M; Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, East Carolina University/ECU Health Medical Center, 601 Moye Blvd, Greenville, NC, 27834, USA., Sewell K; Research Librarian for the Health Sciences, East Carolina University, Greenville, NC, USA., Tillmann HL; Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, East Carolina University/ECU Health Medical Center, 601 Moye Blvd, Greenville, NC, 27834, USA. Tillmannh14@ecu.edu.; Greenville VA Health Care Center, Greenville, NC, USA. Tillmannh14@ecu.edu.
Publikováno v:
Digestive diseases and sciences [Dig Dis Sci] 2023 Dec; Vol. 68 (12), pp. 4511-4520. Date of Electronic Publication: 2023 Oct 27.
Autor:
Halegoua-DeMarzio D; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA., Navarro VJ; Jefferson-Einstein Medical Center, Philadelphia, PA, USA. victor.navarro@jefferson.edu., Davis A; Jefferson-Einstein Medical Center, Philadelphia, PA, USA., Ahmad J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Avula B; University of Mississippi, Oxford, MS, USA., Barnhart H; Duke University, Durham, NC, USA., Barritt AS 4th; University of North Carolina, Chapel Hill, NC, USA., Bonkovsky HL; Wake Forest University School of Medicine, Winston-Salem, NC, USA., Chen VL; University of Michigan, Ann Arbor, MI, USA., Choi G; University of California, Los Angeles, LA, USA., Fontana RJ; University of Michigan, Ann Arbor, MI, USA., Ghabril MS; Indiana University School of Medicine, Indianapolis, IN, USA., Khan I; University of Mississippi, Oxford, MS, USA., Koh C; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA., Odin J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rockey DC; Medical University of South Carolina, Charleston, SC, USA., Rostami H; Duke University, Durham, NC, USA., Serrano J; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA., Sherker AH; National Cancer Institute, NIH, Bethesda, MD, USA., Stolz A; University of Southern California, Los Angeles, CA, USA., Tillmann HL; East Carolina University, Greenville, NC, USA., Vuppalanchi R; Indiana University School of Medicine, Indianapolis, IN, USA.
Publikováno v:
Drug safety [Drug Saf] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.
Autor:
Ali H; Department of Gastroenterology, Hepatology & Nutrition ECU Health Medical Center, Brody School of Medicine Greenville North Carolina USA., Ishtiaq R; Department of Internal Medicine University of Connecticut Health Center Farmington Connecticut USA., Tedder B; Department of Internal Medicine ECU Health Medical Center, Brody School of Medicine Greenville North Carolina USA., Zweigle J; Department of Internal Medicine ECU Health Medical Center, Brody School of Medicine Greenville North Carolina USA., Nomigolzar R; Ross University School of Medicine Bridgetown Barbados., Dahiya DS; Department of Internal Medicine Central Michigan College of Medicine Saginaw Michigan USA., Moond V; Department of Internal Medicine Saint Peter's University Hospital, Robert Wood Johnson Medical School New Brunswick New Jersey USA., Humza Sohail A; Department of Surgery NYU Langone Health Long Island New York USA., Patel P; Department of Gastroenterology Mather Hospital, Hofstra University Zucker School of Medicine Port Jefferson New York USA., Basuli D; Department of Internal Medicine ECU Health Medical Center, Brody School of Medicine Greenville North Carolina USA., Tillmann HL; Department of Gastroenterology, Hepatology & Nutrition ECU Health Medical Center, Brody School of Medicine Greenville North Carolina USA.
Publikováno v:
JGH open : an open access journal of gastroenterology and hepatology [JGH Open] 2024 Apr 15; Vol. 8 (4), pp. e13064. Date of Electronic Publication: 2024 Apr 15 (Print Publication: 2024).
Autor:
Merz M; Michael Merz Consulting, Freiburg, Germany.; Mechanistic Safety, Patient Safety and Pharmacovigilance, Global Drug Development, Novartis, Basel, Switzerland., Fettiplace A; Fettiplace Consulting Ltd, Letchworth Garden City, UK., Marcinak J; Medical Safety Evaluation, Pharmacovigilance and Patient Safety, AbbVie, North Chicago, IL, USA., Tillmann HL; Division Gastroenterology, Hepatology & Nutrition, Department of Medicine, East Carolina University, Greenville, NC, USA., Rockey DC; Digestive Disease Research Center, Medical University of South Carolina, Charleston, SC, USA., Kullak-Ublick GA; Mechanistic Safety, Patient Safety and Pharmacovigilance, Global Drug Development, Novartis, Basel, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Publikováno v:
Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Apr; Vol. 23 (4), pp. 527-537. Date of Electronic Publication: 2024 Apr 04.
Autor:
Poola S; Department of Medicine, East Carolina University, Greenville, NC, USA.; Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, East Carolina University, Greenville, NC, USA.; Vidant Medical Center, Greenville, NC, USA., Sanaka S; Department of Medicine, East Carolina University, Greenville, NC, USA.; Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, East Carolina University, Greenville, NC, USA.; Vidant Medical Center, Greenville, NC, USA., Sewell K; Research Librarian for the Health Sciences, East Carolina University, Greenville, NC, USA., Tillmann HL; Department of Medicine, East Carolina University, Greenville, NC, USA.; Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, East Carolina University, Greenville, NC, USA.; Vidant Medical Center, Greenville, NC, USA.
Publikováno v:
Journal of viral hepatitis [J Viral Hepat] 2021 Feb; Vol. 28 (2), pp. 373-382. Date of Electronic Publication: 2020 Nov 02.
ObjectiveWe hypothesized that a drug-characteristic DILI-phenotype could be defined and be used to develop a computer-assisted DILI causality assessment-tool (DILI-CAT).DesignA drug-specific DILI-phenotype was developed for amoxicillin-clavulanate (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::215bb8e8b153155fbc417b489fcaed62
https://doi.org/10.1101/2021.03.05.21252982
https://doi.org/10.1101/2021.03.05.21252982
Autor:
Poola S; Division of Gastroenterology Hepatology & Nutrition, Department of Medicine, East Carolina University/Vidant Medical Center, Greenville, North Carolina., Kratzer M; Department of Internal Medicine, East Carolina University/Vidant Medical Center, Greenville, North Carolina., Sanaka S; Vidant Medical Center, Greenville, North Carolina., Sewell K; Research Librarian for the Health Sciences, East Carolina University, Greenville, North Carolina., Tillmann HL; Division of Gastroenterology, Hepatology & Nutrition, Department of Medicine, East Carolina University/Vidant Medical Center, Greenville, North Carolina. Electronic address: Tillmannh14@ecu.edu.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2023 Apr; Vol. 21 (4), pp. 1103-1104.e3. Date of Electronic Publication: 2022 Feb 18.
Autor:
Jachs M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III , Medical University of Vienna , Vienna , Austria., Tillmann HL; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Brody School of Medicine , East Carolina University , Greenville , North Carolina , USA.; Greenville VA Health Care Center , Greenville , North Carolina , USA.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2023 Feb 01; Vol. 77 (2), pp. 352-354. Date of Electronic Publication: 2022 Oct 11.
Autor:
Tillmann HL; Division of Gastroenterology, Hepatology & Nutrition, East Carolina University, Greenville, NC, United States of America.; Greenville VA Health Care Center, Greenville, NC, United States of America., Suzuki A; Duke University Medical Center, Durham, NC, United States of America.; Durham VA Medical Center, Durham, NC, United States of America., Merz M; AstraZeneca, independent consultant, Freiburg, Germany., Hermann R; AstraZeneca, Gaithersburg, MD, United States of America., Rockey DC; Digestive Disease Research Center, Medical University South Carolina, Charleston, SC, United States of America.
Publikováno v:
PloS one [PLoS One] 2022 Sep 29; Vol. 17 (9), pp. e0271304. Date of Electronic Publication: 2022 Sep 29 (Print Publication: 2022).